J
Jeffrey L. Evelhoch
Researcher at Merck & Co.
Publications - 100
Citations - 9612
Jeffrey L. Evelhoch is an academic researcher from Merck & Co.. The author has contributed to research in topics: In vivo & Magnetic resonance imaging. The author has an hindex of 37, co-authored 99 publications receiving 8802 citations. Previous affiliations of Jeffrey L. Evelhoch include United States Military Academy & Lincoln's Inn.
Papers
More filters
Journal ArticleDOI
Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.
Paul S. Tofts,Gunnar Brix,David L. Buckley,Jeffrey L. Evelhoch,Elizabeth Henderson,Michael V. Knopp,Henrik Larsson,Ting-Yim Lee,Nina A. Mayr,Geoffrey J. M. Parker,Ruediger E. Port,June S. Taylor,Robert M. Weisskoff +12 more
TL;DR: A standard set of quantity names and symbols related to the estimation of kinetic parameters from dynamic contrast‐enhanced T1‐weighted magnetic resonance imaging data, using diffusable agents such as gadopentetate dimeglumine (Gd‐DTPA), are described.
Journal ArticleDOI
Imaging biomarker roadmap for cancer studies.
James P B O'Connor,Eric O. Aboagye,Judith E. Adams,Hugo J.W.L. Aerts,Hugo J.W.L. Aerts,Sally F. Barrington,Ambros J. Beer,Ronald Boellaard,Sarah E. Bohndiek,J. Michael Brady,Gina Brown,David L. Buckley,Thomas L. Chenevert,Laurence P. Clarke,Sandra Collette,Gary Cook,Nandita M. deSouza,John Dickson,Caroline Dive,Jeffrey L. Evelhoch,Corinne Faivre-Finn,Ferdia A. Gallagher,Fiona J. Gilbert,Robert J. Gillies,Vicky Goh,John R. Griffiths,Ashley M. Groves,Steve Halligan,Adrian L. Harris,David J. Hawkes,Otto S. Hoekstra,Erich P. Huang,Brian Hutton,Edward F. Jackson,Gordon C Jayson,Andrew J. I. Jones,Dow-Mu Koh,Denis Lacombe,Philippe Lambin,Nathalie Lassau,Martin O. Leach,Ting-Yim Lee,Edward Leen,Jason S. Lewis,Yan Liu,Mark F. Lythgoe,Prakash Manoharan,Ross J. Maxwell,Kenneth A. Miles,Bruno Morgan,Steve Morris,Tony Ng,Anwar R. Padhani,Geoff J M Parker,Mike Partridge,Arvind P. Pathak,Arvind P. Pathak,Andrew C. Peet,Shonit Punwani,Andrew R. Reynolds,Simon P. Robinson,Lalitha K. Shankar,Ricky A. Sharma,Dmitry Soloviev,Sigrid Stroobants,Daniel C. Sullivan,Stuart A. Taylor,Paul S. Tofts,Gillian M. Tozer,Marcel van Herk,Simon Walker-Samuel,James Wason,Kaye J. Williams,Paul Workman,Thomas E. Yankeelov,Kevin M. Brindle,Lisa M. McShane,Alan Jackson,John C. Waterton +78 more
TL;DR: Experts assembled to review, debate and summarize the challenges of IB validation and qualification produced 14 key recommendations for accelerating the clinical translation of IBs, which highlight the role of parallel (rather than sequential) tracks of technical validation, biological/clinical validation and assessment of cost-effectiveness.
Journal ArticleDOI
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations
Martin O. Leach,Kevin M. Brindle,Jeffrey L. Evelhoch,John R. Griffiths,Michael R. Horsman,Alan Jackson,Gordon C Jayson,Ian Judson,Michael V. Knopp,R. J. Maxwell,D McIntyre,Anwar R. Padhani,Patricia M Price,R Rathbone,Gordon J. S. Rustin,Paul S. Tofts,Gillian M. Tozer,W Vennart,John C. Waterton,Stephen R. Williams,Paul Workman +20 more
TL;DR: The outcome of a workshop that considered the methodology and design of magnetic resonance studies is reported, recommending how this new tool might best be used.
Journal ArticleDOI
Key factors in the acquisition of contrast kinetic data for oncology.
TL;DR: Several aspects of data acquisition should be taken into account when developing protocols for DCE‐MRI regardless of how the data are analyzed, including the relationship between signal enhancement and contrastAgent concentration, intra‐ or inter‐patient variation in the blood contrast agent concentration as a function of time.
Journal ArticleDOI
Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study
William G. Negendank,R. Sauter,Truman R. Brown,Jeffrey L. Evelhoch,Andrea Falini,Efstathios D. Gotsis,Arend Heerschap,Kyousuke Kamada,Benjamin C. P. Lee,Michel M. Mengeot,Ewald Moser,Kristin Padavic-Shaller,John A. Sanders,Thomas A. Spraggins,Arthur E. Stillman,Burckhard Terwey,Thomas J. Vogl,Karsten Wicklow,Robert A. Zimmerman +18 more
TL;DR: Each type and grade of tumor is a metabolically hetero-geneous group and the hypothesis that mobile lipids observed in vivo in 1H-MR spectroscopy may correlate independently with prognosis of individual patients is hypotheses.